MCRPC

Clinical trials for MCRPC explained in plain language.

Never miss a new study

Get alerted when new MCRPC trials appear

Sign up with your email to follow new studies for MCRPC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 3 Not yet recruiting 1 Not yet finished but already full! 3 Completed 1

Immune priming therapy shows promise in tough prostate cancer

Disease control Completed

This early-phase study tested a new cell therapy called INKmune in 12 men with advanced prostate cancer that no longer responds to hormone therapy. The treatment aims to boost the body's natural killer cells to fight the cancer. Researchers looked for the safest and most effectiv…

Matched conditions: MCRPC

Phase: PHASE1, PHASE2 • Sponsor: Inmune Bio, Inc. • Aim: Disease control

Last updated May 17, 2026 08:47 UTC

MCRPC

Get alerted when new MCRPC trials appear

Immune priming therapy shows promise in tough prostate cancer